TABLE 1.

Demographic and clinical characteristics of study subjects

SubjectAge (yr)RacePrior therapyaHIV-1 riskbCD4+ T cell count (cells/mm3)HIV-1 RNA in plasma (copies/ml)
137CaucasianYesM16974,335
343BlackNoM464149,049
433HispanicYesM, I16318,742
524CaucasianYesM, I28235,331
1032CaucasianNoM, I34229,144
1144CaucasianNoM591166,875
1338CaucasianNoM, I10746,390
1740CaucasianNoM5711,673
2050CaucasianNoI2154,380
2332CaucasianNoM72610,022
2535CaucasianNoM55323,145
2635HispanicYesM473538
  • a Subjects with a prior history of antiretroviral therapy, which in all instances was limited to nucleoside analog reverse transcriptase inhibitor treatment.

  • b M, men having sex with men; I, intravenous drug use.